Brilinta and Neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Neoplasm malignant is reported as a side effect among people who take Brilinta (ticagrelor), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Baby Aspirin, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Neoplasm malignant when taking Brilinta. It is created by eHealthMe based on reports of 22,127 people who have side effects when taking Brilinta from the FDA, and is updated regularly.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,536 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.

On Jul, 14, 2026

22,127 people reported to have side effects when taking Brilinta.
Among them, 47 people (0.21%) have Neoplasm malignant.

Could Brilinta cause Neoplasm malignant?

Among these 47 people:

How long have people been on Brilinta when they have Neoplasm malignant? *

What is the gender of people who have Neoplasm malignant when taking Brilinta? *

female: 52.5 %
male: 47.5 %

What is the age of people who have Neoplasm malignant when taking Brilinta? *

What are other drugs people take besides Brilinta? *

What are other side effects people have besides Neoplasm malignant? *

Dyspnea (difficult or laboured breathing): 9 people, 19.15%
Cardiac Arrest: 4 people, 8.51%
Weight Increased: 3 people, 6.38%
High Blood Pressure: 3 people, 6.38%
Chest Pain: 3 people, 6.38%
Cardiac Disorder: 3 people, 6.38%
Thyroid Diseases: 3 people, 6.38%
Thyroid Cancer: 3 people, 6.38%
Chronic Kidney Disease: 2 people, 4.26%
Ill-Defined Disorder: 2 people, 4.26%

What are the existing conditions these people have? *

Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 13 people, 27.66%
Cardiac Disorder: 5 people, 10.64%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 6.38%
High Blood Pressure: 3 people, 6.38%
Stress And Anxiety: 3 people, 6.38%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 4.26%
High Blood Cholesterol: 2 people, 4.26%
Multiple Allergies (allergy to multiple agents): 2 people, 4.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.26%
Diabetes: 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Brilinta and have Neoplasm malignant?

- Check whether Neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Brilinta:

Brilinta (22,469 reports)

Browse all side effects of Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm malignant:

Neoplasm malignant (1,537 drugs)

Browse all the conditions that are associated with Neoplasm malignant:

Neoplasm malignant (1,261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ticagrelor (the active ingredients of Brilinta) and Brilinta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.